https://doi.org/10.5812/jjnpp-154579

A Novel Platform for Controlled Drug Delivery and Dye Removal; Green Synthesis and Characterization of Honey-Incorporated Cu/Al Layered Double Hydroxide (LDH) Nanocomposite

authors:

avatar Amir Mohammad Bagheri ORCID 1 , 2 , * , avatar Mehdi Ranjbar ORCID 2

Student Research Committee, Kerman University of Medical Sciences, Kerman, Iran
Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran
Jundishapur Journal of Natural Pharmaceutical Products: Vol.20, issue 1; e154579
published online: February 1, 2025
article type: Research Article
received: September 15, 2024
revised: December 17, 2024
accepted: December 17, 2024

How To Cite? Bagheri A M, Ranjbar M. A Novel Platform for Controlled Drug Delivery and Dye Removal; Green Synthesis and Characterization of Honey-Incorporated Cu/Al Layered Double Hydroxide (LDH) Nanocomposite. Jundishapur J Nat Pharm Prod. 2025;20(1):e154579. https://doi.org/10.5812/jjnpp-154579.

Abstract

Background:

Recently, introducing new drug delivery approaches to maintain drug concentrations at reasonable levels for longer periods is widely emerging in pharmaceutical science. In this respect, multilamellar nanomaterials such as layered double hydroxide (LDH) nanocomposites are considered favorable topics due to their high specific surface areas and abundant interlayer spaces for drug loading, as well as appropriate properties, including ease of synthesis, high thermodynamic stability, and controlled drug delivery.

Objectives:

In the current study, we aimed to prepare a honey-incorporated Cu/Al-LDH (Ho@Cu/Al-LDH) nanocomposite as a platform for controlled drug delivery using ibuprofen (Ibu) as a model pharmaceutical agent. Additionally, the dye removal potential of this nanocomposite was also assessed.

Methods:

Cu/Al-LDH nanocomposite was prepared using honey as an anionic ligand by hydrothermal precipitation. The product was collected and dried after several washing steps. Subsequently, the prepared nanocomposite was evaluated through physicochemical properties, dye removal potential, total antioxidant capacity, and entrapment efficiency as well as drug release properties.

Results:

The Ho@Cu/Al-LDH nanocomposite exhibited good physicochemical properties with an average particle size of 123.7 nm and a PDI of 0.37, as well as relative uniformity and suitable morphology. The nanocomposite also presented good antioxidant properties [ferric reducing antioxidant power (FRAP) value of 298.42 ± 0.93 μM Fe(II)/g], high entrapment efficiency (EE) during the evaluation, and a pH-dependent controlled release profile (42.3 ± 0.243% at pH 7.4 and 0.481 ± 32.1% at pH 9.5), which was in good agreement with the Korsmeyer-Peppas model.

Conclusions:

However, the incorporation of natural compounds into LDHs is no longer restricted. In particular, the present study introduces a promising approach to reduce dose-related adverse effects and address health concerns by developing organic-inorganic nanocomposites for controlled drug delivery. In addition, this nanocomposite can also be used as an effective and low-cost recyclable adsorbent.

1. Background

In recent years, drug delivery approaches have received extensive attention in pharmaceutical science. From this perspective, drug administration through controlled delivery systems is a favorable topic (1-3). These systems maintain the drug concentration at intended levels for a longer period, subsequently decreasing the dosing intervals. Moreover, conventional approaches are usually associated with adverse effects and treatment failure, leading to an increased demand for new drug carriers (4-7). Recently, spectacular advances in nanomaterials have been noticed in the field of drug delivery due to their unique properties, such as a high surface-to-volume ratio, customizable particle size, and high solubility. As a class of nanocomposites, layered double hydroxide (LDH) nanoparticles, also known as anionic clays or hydrotalcite-like systems, have shown the capacity to preserve drug molecules in the interlayer spaces (8, 9). Originally derived from the structure of brucite (Mg (OH)2), these layered nanostructures can be formed by replacing a part of divalent cations with trivalent cations, typically stabilized by exchangeable interlayer anionic species (either inorganic or organic) and water molecules. Regarding the size/charge ratio of anions and the dimensions of guest species, there should be a host-guest relationship between them. In this context, LDH nanoparticles can be easily manipulated for intercalating various drug molecules with many metal-anion combinations and possible compositions to reduce the degradation rate and provide a sustained release profile (10, 11).

By incorporating a polymer into LDH nanoparticles, a polymer-based nanocomposite film can be obtained with unique functions and structures, which can be defined as solution intercalation, melt intercalation, or emulsion intercalation through a layer-by-layer self-assembly method (12, 13). In the field of drug delivery, the utilization of inorganic materials may be associated with the production of harmful byproducts and environmental impacts. Instead, using natural substances and green synthesizing methodologies can minimize energy consumption and pollutant production, as well as improve human health (14, 15). Accordingly, natural-derived substances (such as honey) that structurally consist of several organic macromolecules (like carbohydrates, proteins, nucleic acids, and fatty acids) are drawing interest (16, 17). Natural-based nanocomposite materials are generally considered non-toxic and biocompatible, with high chemical stability and pH-dependent solubility (12, 18). They are prepared through inexpensive processes and can be easily modified with unique physicochemical properties for different applications such as environmental science, catalysis, biosensing, cosmetics, and medicine (10, 19). Although switching to biological sources might address numerous significant problems, the possibility of rapid degradation of active ingredients during storage, either by hydrolysis or oxidation, and inadequate therapeutic responses due to restricted release profiles highlight the necessity of introducing drug delivery systems that can address these issues (20).

2. Objectives

Therefore, the current work was proposed to introduce a new drug delivery platform that can preserve active ingredients from rapid degradation and provide a prolonged release profile by using natural-derived substances. Accordingly, we aimed to green synthesize and evaluate the physicochemical characteristics of a natural-based nanocomposite using honey as an interfacial ligand, named honey-incorporated Cu/Al-LDH (Ho@Cu/Al-LDH) nanocomposite. In this respect, ibuprofen (Ibu; a poorly water-soluble drug prone to immediate degradation in extreme environments) was chosen as a model pharmaceutical agent to investigate the potential applications of this system for controlled drug delivery. Further, the dye removal potential of this nanocomposite was also assessed as a low-cost and recyclable adsorbent.

3. Methods

3.1. Materials

Cupric nitrate trihydrate (Cu(NO3)2·3H2O), aluminum nitrate nonahydrate (Al(NO3)3·9H2O), 2,4,6-Tris(2-pyridyl)-s-triazine (TPTZ), ascorbic acid, sodium acetate (CH3COONa), acetic acid (CH3COOH), ferric chloride (FeCl36H2O), ferrous sulfate (FeSO47H2O), methylene blue, and Ibu (98% purity) were purchased from Sigma-Aldrich, Germany. Honey was derived from Lalezar, Kerman province, Iran. Sodium hydroxide (NaOH), hydrochloric acid (HCl), and ethanol (96%) were purchased from Merck, Germany.

3.2. Preparation of Ho@Cu/Al- Layered Double Hydroxide Nanocomposite

The Cu/Al-LDH nanoparticles were prepared using honey as an anionic ligand based on previous literature by a co-precipitation-assisted hydrothermal method (21-23). Briefly, 2.5% w/v of Cu(NO3)2· 3H2O and Al(NO3)3·9H2O in a 2:1 molar ratio were dissolved in 20 mL of a water/ethanol (1:1) solution. To increase the pH of the solution to 9.5, NaOH (2 M) was added along with magnetic stirring (400 rpm for 2 hours at 50°C). Subsequently, the solution was mixed with 5% w/v of honey, and stirring continued for a further 4 hours under an argon atmosphere. It was then poured into the autoclave and heated for 8 hours at 110°C. Afterward, the product was collected and dried at 80°C overnight, followed by several washing steps with water/ethanol solution to remove excess anions and obtain the Ho@Cu/Al-LDH nanocomposite (18, 21, 24). However, no attention was paid to control other physicochemical properties.

3.3. Physicochemical Characterization

Following the preparation of the Ho@Cu/Al-LDH nanocomposite, physicochemical properties were assessed. High-performance thin-layer chromatography (HPTLC) was employed to confirm the presence of honey in the product using water/ethanol (1:1) solution and Silica gel 60 F254 HPTLC aluminum plates (10 × 10 cm; Merck, Germany) as the mobile and stationary phases, respectively (25-27). Following the advancement in a developing chamber, densitometry analysis (CAMAG TLC Scanner 3, Switzerland) was used to quantify the bands at 254 nm using WIN CATS software (version 4 X) (28). The physical stability was also assessed using centrifugation durability and thermodynamic accelerated tests (heating-cooling and freeze-thaw cycles), while visually observing for any changes (29). The dynamic light scattering (DLS) method (VASCO®, Cordouan Technologies, France) was used to determine the average particle size and polydispersity index (PDI). It is a rapid and non-destructive method based on Brownian motion in the liquid phase (30, 31). Additionally, the morphology and uniformity of the prepared nanocomposite were assessed using scanning electron microscopy (SEM) analysis with an acceleration voltage of 15 kV (FE-SEM, MIRA 3 XM, Tescan Inc., USA) according to previously reported literature (32, 33).

3.4. Study of Dye Removal Potential

Based on previously reported literature, the potential dye removal applications of the prepared nanocomposite were also assessed (23, 33, 34). Accordingly, the sample suspension (dispersed in water/ethanol (1:1) solution) was mixed with a methylene blue diluted solution (100 ppm) at room temperature with continuous stirring (150 rpm for 2 hours). The liquid and solid phases were separated by filtering, and the quantity of methylene blue was then calculated at predetermined intervals using a UV spectrophotometer (λmax: 664 nm). The experiment was conducted in triplicate at two different pH values (7.4 and 9.5), and dye removal (%) was reported as mean ± SD.

3.5. Study of Total Antioxidant Capacity

The ferric reducing antioxidant power (FRAP) assay was conducted to evaluate the total antioxidant capacity of the Ho@Cu/Al-LDH nanocomposite with slight modifications (35-37). Accordingly, 200 μL of the sample suspension was mixed with 1800 μL of FRAP reagent, which contained 2.5 mL of TPTZ solution (5 mM of TPTZ in 20 mM HCl), 2.5 mL of FeCl3·6H2O solution (20 mM), and 25 mL of acetate buffer (300 mM, pH 3.6), followed by incubation in the dark (tubes covered with aluminum foil) for 10 minutes at 25°C. Using aqueous solutions (50 to 1000 μM) of ferrous sulfate heptahydrate (FeSO4⋅7H2O), the standard calibration curve was plotted at 593 nm. The experiment was conducted in triplicate during a 30-day assessment. Results were compared to ascorbic acid and reported as mean ± SD. Eventually, the FRAP value was determined as the micromolar equivalent of ferrous in the sample mass (μM Fe (II)/g). Theoretically, different concentrations of an antioxidant agent cause changes in the FRAP assay absorbance equivalent to Fe(II) solution (1 μM).

3.6. Study of Entrapment Efficiency and Drug Release

To evaluate the potential applications of this nanocomposite for controlled drug delivery, Ibu was chosen as a model pharmaceutical agent. Therefore, the entrapment efficiency (EE) of Ibu-loaded Ho@Cu/Al-LDH (Ibu-Ho@Cu/Al-LDH) nanocomposite was studied with reference to previously reported studies (22, 38, 39). Primarily, the calibration curve of Ibu was plotted at λmax (228 nm) and linearity was checked (R² = 0.996; LOD: 3.78 and LOQ: 12.56 ppm). Next, the sample suspension was mixed with Ibu solution (10 mg/mL) by continuous stirring (100 rpm) for 10 hours at room temperature. Afterward, 100 μL of the prepared nanocomposite was diluted with a water/ethanol solution (1:1), and the concentration of Ibu was measured using UV spectrophotometric analysis. The experiment was conducted in triplicate, and Ibu content (%) was reported as mean ± SD according to Equation 1:

EE % = (Wt/Wi) ×100

Wt is the total amount of Ibu determined in the Ibu-Ho@Cu/Al-LDH nanocomposite, and Wi is the total quantity of Ibu used. To ensure there is no interference from other components, the unloaded formulation was used as a blank. The release profile of the prepared nanocomposite was assessed under sink conditions using a Franz diffusion cell with slight modifications (2, 21, 22). The cellophane membrane (synthetic semi-permeable membrane with a molecular weight cut-off of 12 kDa) was deposited in the receiving medium for complete saturation overnight. The formulation was poured into the donor compartment, and sampling was carried out under constant conditions (stirring at 200 rpm and 37 ± 1°C) at predetermined intervals. Subsequently, samples were subjected to UV spectrophotometry analysis at λmax. The release profile of the Ibu-Ho@Cu/Al-LDH nanocomposite was assessed under two different pH levels (7.4 and 9.5). Moreover, the release profile of pure Ibu (dissolved in water/ethanol) was also evaluated to provide a better concept. The experiment was conducted in triplicate, and results were expressed as mean ± SD.

Following, different kinetic models (zero-order, first-order, Higuchi, Hixon-Crowell, and Korsmeyer-Peppas) were mapped to define diffusion characteristics and the release profile. In this respect, the best-fitted equation was selected based on the R² value approaching and the slope of the respective plots. Further, the Akaike Information Criterion (AIC) was also used to test the goodness of fit according to the maximum likelihood using the KinetDS software program (KinetDS 3.0). This statistical measure is used to assess the applicability of models for a given set of data in terms of their predictive accuracy and relative performance (40, 41). When comparing several models, the one with the minimum AIC value is considered the best fit according to Equation 2:

AIC = n × ln (WSSR) + 2p

Where n is the number of sampling intervals (release data points), p stands for the number of parameters (independent variables) in the model, and WSSR is the abbreviation for the weighted sum of squares of residues, estimated by Equation 3:

WSSR =∑i=1nwiyi-yi'2

Aaccording, wi is an optional weighing factor, yi denotes observed value, and y'i stands for predicted value.

4. Results and Discussion

4.1. Physicochemical Characterization

The result of the HPTLC profile is illustrated in Figure 1. Accordingly, there is a high accordance between the yielding band of honey and the prepared nanocomposite, indicating the presence of ligands in this nanostructure. The HPTLC analysis can create a chromatographic fingerprint in the form of a unique sequence of peaks corresponding to the entire analyzed sample (28). Megalathan et al. (42) used thin layer chromatography (TLC) analysis to evaluate the intercalation of curcuminoids into Mg/Al LDH nanoparticles. Shi et al. (25) investigated the chelator-free labeling potential of Mg/Al-LDH nanoparticles coated by bovine serum albumin for different isotopes using TLC, as this method can determine the unbound samples. In another study, Gilanizadeh and Zeynizadeh used HPTLC analysis to assess the purity of substrates and products as well as to monitor the completion of synthesis reactions (26). Khashaba et al. synthesized Fe3O4/FeOOH magnetic nanocomposites for the extraction of triptan family members (such as zolmitriptan) using HPTLC determination in the presence of paracetamol and metoclopramide (43).

The high-performance thin-layer chromatography (HPTLC) profile for honey and Cu/Al-LDH nanoparticles
The high-performance thin-layer chromatography (HPTLC) profile for honey and Cu/Al-LDH nanoparticles
Figure 1.

The high-performance thin-layer chromatography (HPTLC) profile for honey and Cu/Al-LDH nanoparticles

According to the thermodynamic accelerated stability tests, the prepared nanocomposite demonstrated acceptable physical stability. Visually, there was no sign of fickleness or inconsistency following the heating-cooling and freeze-thaw cycles. The structure also exhibited high durability in the centrifugation cycle, indicating good mechanical strength. Figure 2 shows the results of DLS analysis and SEM imaging. Based on the DLS results, the average particle size of Cu/Al-LDH nanoparticles was approximately 123.7 nm with a PDI of 0.37, indicating a high degree of uniformity. The PDI is a measure of the size distribution in a given sample. PDI values range from 0 to over 1, where a lower PDI value indicates higher homogeneity. Systems with a high degree of homogeneity are anticipated to have a greater predictive capability for physicochemical properties, stability during storage, and release parameters. Similar to the DLS data, SEM micrographs also indicated a restricted range for particle size distribution. However, the presence of some coarse particles in the product might emphasize the necessity of fine milling.

The results of particle size analysis by A, DLS method; and B, SEM imaging for Cu/Al-LDH nanoparticles
The results of particle size analysis by A, DLS method; and B, SEM imaging for Cu/Al-LDH nanoparticles
Figure 2.

The results of particle size analysis by A, DLS method; and B, SEM imaging for Cu/Al-LDH nanoparticles

4.2. Study of Dye Removal Potential

Figure 3 represents the results of the adsorbent profile and dye removal potential for methylene blue. Accordingly, an alkaline pH (9.5) provides a better adsorbent profile due to the higher presence of OH⁻ anions, as the LDH structure becomes positively rigid in alkaline conditions. Dye removal is an important process for industrial wastewater treatment, which can be achieved by several techniques, including chemical oxidation, membrane technology, coagulation, photocatalytic degradation, and physical adsorption. Among these, adsorption is considered the most effective technique due to its low cost, simple design, and high efficiency. This process might depend on several factors such as adsorbent amount, contact time, initial dye concentration, and pH (44, 45). So far, various adsorbents such as carbon-based materials, metal oxides, and polymers have been used to effectively remove pollutants. These adsorbents work by intercalating/capturing dye molecules and thus purifying the wastewater. Therefore, LDH nanocomposites might be of interest due to their multilamellar structure, abundant interlayer spaces, limited toxicity, facile synthesis, and high stability (46, 47).

Result of dye removal in two different pHs (7.4 and 9.5)
Result of dye removal in two different pHs (7.4 and 9.5)
Figure 3.

Result of dye removal in two different pHs (7.4 and 9.5)

Abdel-Hady et al. assessed the adsorption pattern and textural properties of Zn/Mg/Al-LDH toward crystal violet dye as a low-cost and recyclable adsorbent (23). Based on their study, the synthesized LDH platform shows a pH-sensitive behavior with higher dye removal in alkaline conditions. Other factors that positively affect dye adsorption include contact time, initial dye concentration, and the LDH dose. However, the excessive presence of LDH in the test environment can become an obstacle for the active sites, leading to aggregation of LDH layers and reduction of the adsorbent surface area. In another study, Yadav and Dasgupta evaluated the potential of Mg/Al-LDH for the adsorption of methyl orange dye from aqueous solutions (48). Accordingly, particles with a size range of 60 to 120 nm were synthesized by the co-precipitation method under a nitrogen atmosphere, while the pH and temperature of the dye solution had a major effect on the adsorption kinetics. de Sá et al. investigated the effects of pH, contact time, and dye concentration on the removal properties of the Ca/Al-LDH system for the adsorption of Sunset Yellow FCF food dye (a petroleum-derived orange azo dye) (49). Their results indicated that the pH range of 4.0 to 10 is effective for dye removal, as low pH modifies the surface charge of the adsorbent and potentially increases the degree of dye dissolution from interlayer spaces.

In summary, the present study indicates the possibility of using LDH nanocomposites to develop new adsorbents with elevated pollutant removal capacity for environmental protection.

4.3. Study of Total Antioxidant Capacity

Oxidation is one of the most common degradation pathways of pharmaceutical ingredients. Therefore, introducing drug delivery systems that can combat this challenge and preserve drug molecules from destructive factors is of interest. The FRAP technique exploits antioxidant agents in a redox-linked colorimetric assay, where a higher absorbance indicates a superior FRAP value and greater antioxidant capacity (37, 50). The FRAP value of this nanocomposite was measured to be 298.42 ± 0.93 and 286.37 ± 1.45 μM Fe (II)/g on the production day and after 30 days, respectively, showing minimal alteration. Therefore, this system not only can be a candidate for drug delivery but also can be used to preserve incorporated molecules from immediate degradation followed by oxidation. Fundamentally, the antioxidant capacity refers to the exploitation of honey in this system. Honey consists of several organic molecules (such as terpenoids, alkaloids, and flavonoids) with high antioxidant capacities (16, 51). Several studies have revealed the potential antioxidant properties of honey (52, 53). Neupane et al. studied the antioxidant and antimicrobial properties of iron oxide nanoparticles loaded with Himalayan honey (54). In another study, Keskin et al. synthesized silver nanoparticles based on chestnut honey and evaluated the physicochemical properties for use as a potential drug delivery system in fields such as medicine, pharmaceuticals, and cosmetics (55).

4.4. Study of Entrapment Efficiency and Drug Release

The EE of the Ibu-Ho@Cu/Al-LDH nanocomposite was measured to be 73.15 ± 0.401%, followed by 72.87 ± 0.547% within a 30-day assessment, revealing negligible alteration. In drug delivery systems, content uniformity and chemical stability of loaded ingredients are important for dose retention, as such systems are prone to degradation of loaded molecules or leakage during storage (56). The cumulative in vitro release is shown in Figure 4. The study was conducted at two different pH levels (7.4 and 9.5) for 360 minutes, and the results were compared with the release profile of the pure Ibu solution (Ibu-Sol). A release of 42.3 ± 0.243% of Ibu was observed at pH 7.4 and 32.1 ± 0.481% at pH 9.5 from the Ibu-Ho@Cu/Al-LDH nanocomposite, while 93.4% of pure Ibu-Sol was released. Since Ibu is poorly soluble in water, a water/ethanol (1:1) solution was used as the receiving medium. The significant differences between pure Ibu-Sol and drug-loaded nanocomposites at both pH levels can be explained by the high compatibility of the drug with the receiving medium and the physical intercalation of Ibu into the interlayer spaces of the nanocomposite. The shift in drug release between the two pH levels might be attributed to the different presence of OH⁻ anions, which can alter the composition of the LDH nanocomposite and the characteristics of interlayer spaces. Fundamentally, the quantity and size/charge ratio of anions are crucial for a homogeneous balance between the positively charged layers. In the interlayer spaces, large-sized anions with low charge are unable to organize a host-guest relationship across host layers and guest species. In this context, anions containing long chains (fatty acid esters and long-chain alkyl carboxylates or sulfonates) can be ordered by several arrangements such as monolayer (parallel to the layers), parallel bilayer (tilted monolayers), or bilayers, leading to diversity in the interlayers (10). This functional diversity could be affected within different pH ranges. The working pH should not be lower than 4.0 due to the high fracture possibility of hydroxyl layers. However, LDH is soluble at low pH levels but remains stable at neutral and becomes substantially tightened at alkaline pH levels, expecting a controlled release profile (10, 57).

The results of cumulative release (mean ± SD)
The results of cumulative release (mean ± SD)
Figure 4.

The results of cumulative release (mean ± SD)

Kiani et al. demonstrated the pH sensitivity of Cu–Al LDH nanoparticles for loaded drug (doxorubicin) with higher released amounts in acidic pH ranges compared to neutral (21). Among different methods to overcome gastrointestinal (GI) barriers, pH-sensitive release mechanisms are emerging in oral administration. Although the oral route is recognized as the most common route of administration, molecules may encounter harsh conditions before reaching systemic circulation, particularly different pH ranges (pH 1–7) and destructive enzymes. In this respect, nanocomposites could solve such problems and provide a controlled release profile. By encapsulating LDHs within a pH-sensitive polymeric shell layer (particularly alkaline-solubles that are extensively used in enteric-coated dosage forms), core-shell nanocomposites could be achieved. Accordingly, the LDH nanocomposites would be entirely preserved to reach the intestine, providing a controlled release profile only after polymeric shell decomposition.

Apart from that, the pH sensitivity of drug delivery systems is desired in tumor-targeted therapies as cancerous cells are characterized by a high level of acidity (58). Hence, LDH nanocomposites could be used to provide a prompt release profile in such environments compared to normal ones. In this work, Ibu was chosen as a model pharmaceutical agent, which is commonly associated with adverse effects such as GI ulcers, renal features, and hepatic damage (59). Therefore, scientists have been encouraged to investigate alternative administration routes. Intercalating drugs in interlamellar spaces of nanocomposites not only allows for a controlled release profile and better therapeutic outcomes but also reduces the possibility of adverse effects, as less drug and dosing intervals would be required to achieve the same responses (22, 60).

In a study by Dasgupta, Mg/Al-LDH nanoparticles were synthesized for the intercalation of Ibu into the interlayer space by the co-precipitation method (22). Accordingly, the average particle size was measured to be 55 nm, and the release profile demonstrated to follow the first-order kinetic model in a 16-hour assessment. However, their cumulative release profile yielded 85% after 36 hours at pH 7.4. Wang et al. investigated the controlled release profile and antibacterial activity of synthesized graphene oxide–benzylpenicillin anion intercalated Mg/Al-LDH (GO–BP-LDH) nanohybrid films (61). According to their results, the synthesized GO-BP-LDH nanohybrid films not only provided a controlled release profile but also exhibited enhanced antibacterial activity, possibly due to the synergy of both graphene oxide and benzylpenicillin.

In the current study, different kinetic models were used to describe the release profile of the prepared nanocomposite. In this context, data were assessed, and the best-fitted kinetic model was identified based on the correlation coefficient value (Table 1). The validity of the selected kinetic model was also confirmed by AIC values. This mathematical method estimates the prediction errors and helps to assess the best fitting of a model to the data from which it was generated. Therefore, among models with close R² values, the model that shows a lower AIC value is more reliable. Accordingly, the Korsmeyer-Peppas model was chosen as the best curve fitting in both studied conditions (pH 7.4 and pH 9.5), which expresses the drug release pattern from a polymeric system regarding the exponent (N) of the equation. Theoretically, an N value less than 0.45 (N < 0.45) indicates that the release regime mainly follows hindered (or non-Gaussian) Fickian diffusion, which occurs when movements of loaded molecules are restricted by partially permeable barriers. An N value between 0.45 and 1 (0.45 < N < 1) indicates that loaded molecules would be released through anomalous transport (non-Fickian diffusion), which is attributed to further release mechanisms in addition to diffusion (62). In the current study, the latter kinetic mechanism (observed in the pH 7.4 release profile) may be ascribed to the lower presence of OH⁻ anions and less tightness of structure compared to alkaline conditions (pH 9.5).

Table 1.

Results of Data Fitting Parameters and Akaike Information Criterion Values for Different Kinetic Models in Two Different pHs (7.4 and 9.5)

VariablespH = 7.4pH = 9.5
R2AICKNR2AICKN
Kinetics model
Zero-order0.98684.92220.1351-0.98219.17650.0914-
First-order0.80031.74030.0017-0.80032.28380.0011-
Hixson-Crowell0.94218.09470.0024-0.93657.77920.0016-
Higuchi0.97479.56502.0534-0.92419.30431.3579-
Korsmeyer-Peppas0.99574.68720.00160.97360.98324.76090.06530.4161

Abbreviation: AIC, akaike information criterion.

Salguero et al. designed hybrid composite films using Zn-Al-LDH and hyaluronan (hyaluronic acid) as a delivery platform for intercalating ciprofloxacin (63). Their hybrid composite films, with potential use as an alternative approach for the prevention and treatment of wounds' opportunistic infections, represented a controlled release profile and best-fitted kinetics with Higuchi and Korsmeyer-Peppas models at pH 5.8 and 7.4, respectively. Therefore, after topical administration, this drug delivery system provides sustained release and maintains antibacterial activity at a suitable level along with the healing properties of hyaluronan.

Ranjbar and Namazi introduced Mg/Al-LDH@hydroxyapatite-doxorubicin coated magnetic Fe3O4-polyethylene glycol nanocomposite as a biocompatible and pH-sensitive system for targeted release of doxorubicin (64). The prepared nanocomposite demonstrated high cytotoxicity against MCF-7 cancer cells and a controlled release profile, which was found to be in good agreement with the Korsmeyer-Peppas model. However, the development of new drug delivery systems requires optimizing the release profile to reduce drug-related side effects. Therefore, the incorporation of therapeutic ingredients into nanocomposites is considered a viable approach to minimize adverse effects and address safety issues.

5. Conclusions

The continuous development of drug delivery approaches has led to significant advances in public health. In this context, nanoscience and nano-sized materials are drawing interest due to their promising applications in medicine. As a class of lamellar solids, LDHs can resemble conventional intercalating structures and qualitatively preserve loaded molecules during storage from degradation by harsh environments. These materials are typically prepared through the incorporation of an organic guest into a layered inorganic structure, yielding attractive hybrid organic/inorganic nanocomposites that can be used as carriers of different drugs and bioactive species. Intercalating drugs into the interlayer spaces of LDH nanoparticles can provide a controlled release profile and improve therapeutic responses while reducing adverse effects.

In the current study, we synthesized and evaluated the physicochemical characteristics of Cu/Al-LDH nanoparticles for controlled drug delivery. The prepared formulation exhibited good physicochemical properties with an average particle size of 123.7 nm and a PDI of 0.37. Further, SEM analysis revealed relatively uniform particles and suitable morphology. Additionally, this nanocomposite formulation could be used as an effective and low-cost adsorbent to remove different materials. The removal of pollutants, particularly dyes, is an essential step in wastewater treatment and plant health. Moreover, the Ho@Cu/Al-LDH nanocomposite also revealed good antioxidant properties, which are desirable for preserving oxidation-sensitive molecules during storage. It demonstrated high encapsulation efficiency with negligible alteration throughout the assessment time, as well as a pH-dependent release profile (42.3 ± 0.243% at pH 7.4 and 32.1 ± 0.481% at pH 9.5), following the Korsmeyer-Peppas kinetic model.

The incorporation of natural compounds into LDHs is no longer limited, introducing a suitable approach to minimize adverse effects. In the current study, Ibu was used as a model drug to define the potential applications of this system for controlled drug delivery. Honey was chosen in this system due to its high antioxidant capacity, which can help preserve the loaded molecules from harsh environments. However, the incorporation of natural-derived substances in delivery systems is mainly considered to be safe and biocompatible, providing access to a prolonged release profile. Despite considering the antimicrobial properties of honey, we aim to evaluate the potential antimicrobial properties of this drug delivery system, as well as exploit other pharmaceutical drugs such as antibiotics to achieve synergistic effects and further benefits. Nonetheless, cohort studies on possible toxicity and further applications of LDH nanocomposites should be conducted to assess their safety and feasibility before individual practices.

References

  • 1.

    Girija AR, Balasubramanian S, Cowin AJ. Nanomaterials-based Drug Delivery Approaches for Wound Healing. Curr Pharm Des. 2022;28(9):711-26. [PubMed ID: 35345993]. https://doi.org/10.2174/1381612828666220328121211.

  • 2.

    Raeisi Estabragh MA, Pardakhty A, Ahmadzadeh S, Dabiri S, Malekpour Afshar R, Farajli Abbasi M. Successful Application of Alpha Lipoic Acid Niosomal Formulation in Cerebral Ischemic Reperfusion Injury in Rat Model. Adv Pharm Bull. 2022;12(3):541-9. [PubMed ID: 35935040]. [PubMed Central ID: PMC9348526]. https://doi.org/10.34172/apb.2022.058.

  • 3.

    Lori MS, Ohadi M, Estabragh MAR, Afsharipour S, Banat IM, Dehghannoudeh G. pH-Sensitive Polymer-Based Carriers as a Useful Approach for Oral Delivery of Therapeutic Protein: A Review. Protein Pept Lett. 2021;28(11):1230-7. [PubMed ID: 34303327]. https://doi.org/10.2174/0929866528666210720142841.

  • 4.

    Lee SH, Bajracharya R, Min JY, Han JW, Park BJ, Han HK. Strategic Approaches for Colon Targeted Drug Delivery: An Overview of Recent Advancements. Pharmaceutics. 2020;12(1). [PubMed ID: 31952340]. [PubMed Central ID: PMC7022598]. https://doi.org/10.3390/pharmaceutics12010068.

  • 5.

    Manzari MT, Shamay Y, Kiguchi H, Rosen N, Scaltriti M, Heller DA. Targeted drug delivery strategies for precision medicines. Nat Rev Mater. 2021;6(4):351-70. [PubMed ID: 34950512]. [PubMed Central ID: PMC8691416]. https://doi.org/10.1038/s41578-020-00269-6.

  • 6.

    Raeisi Estabragh MA, Bami MS, Ohadi M, Banat IM, Dehghannoudeh G. Carrier‐Based Systems as Strategies for Oral Delivery of Therapeutic Peptides and Proteins: A Mini‐Review. Int J Peptide Res Therapeut. 2021;27(2):1589-96. https://doi.org/10.1007/s10989-021-10193-0.

  • 7.

    Raeisi Estabragh MA, Sajadi Bami M, Dehghannoudeh G, Noudeh YD, Moghimipour E. Cellulose derivatives and natural gums as gelling agents for preparation of emulgel-based dosage forms: A brief review. Int J Biol Macromol. 2023;241:124538. [PubMed ID: 37085064]. https://doi.org/10.1016/j.ijbiomac.2023.124538.

  • 8.

    Mei X, Xu S, Hu T, Peng L, Gao R, Liang R, et al. Layered double hydroxide monolayers for controlled loading and targeted delivery of anticancer drugs. Nano Research. 2017;11(1):195-205. https://doi.org/10.1007/s12274-017-1619-y.

  • 9.

    Rojas R. LDH nanoparticles: synthesis, size control and applications in nanomedicine. . Fisicoquímica, Argentina: Agricultural Appl Serv; 2015. p. 101-20.

  • 10.

    Mishra G, Dash B, Pandey S. Layered double hydroxides: A brief review from fundamentals to application as evolving biomaterials. Appl Clay Sci. 2018;153:172-86. https://doi.org/10.1016/j.clay.2017.12.021.

  • 11.

    Elbasuney S. Surface engineering of layered double hydroxide (LDH) nanoparticles for polymer flame retardancy. Powder Technol. 2015;277:63-73. https://doi.org/10.1016/j.powtec.2015.02.044.

  • 12.

    Kuthati Y, Kankala RK, Lee C. Layered double hydroxide nanoparticles for biomedical applications: Current status and recent prospects. Appl Clay Sci. 2015;112-113:100-16. https://doi.org/10.1016/j.clay.2015.04.018.

  • 13.

    Alcântara ACS, Aranda P, Darder M, Ruiz-Hitzky E. Bionanocomposites based on alginate–zein/layered double hydroxide materials as drug delivery systems. J Materials Chem. 2010;20(42). https://doi.org/10.1039/c0jm01211d.

  • 14.

    Thongnopkun P, Jamkratoke M, Jitkam Y. Green synthesis and characterization of silver nanoparticle using natural reducing sugar from cultivated banana peel (Conference Series). J Physics. 2018;1144. https://doi.org/10.1088/1742-6596/1144/1/012159.

  • 15.

    Sun X, Neuperger E, Dey SK. Insights into the synthesis of layered double hydroxide (LDH) nanoparticles: Part 1. Optimization and controlled synthesis of chloride-intercalated LDH. J Colloid Interface Sci. 2015;459:264-72. [PubMed ID: 26301838]. [PubMed Central ID: PMC4706763]. https://doi.org/10.1016/j.jcis.2015.07.073.

  • 16.

    Shamaki B, Abba Y, Balla H, Gambo H, Sherifat O, Abdulrahman FI, et al. Evaluation of Chemical Composition and the Comparative Wound Healing Effect of Natural Honey and Olive Oil in Rabbits. Communications in Appl Sci. 2014;2:149-69.

  • 17.

    Barman DN, Rahman MA, Hossain MM. Lipid and Fatty Acids in Honey. Honey. 2023. p. 46-9. https://doi.org/10.1002/9781119113324.ch4.

  • 18.

    DeLeon VH, Nguyen TD, Nar M, D'Souza NA, Golden TD. Polymer nanocomposites for improved drug delivery efficiency. Materials Chem Physics. 2012;132(2-3):409-15. https://doi.org/10.1016/j.matchemphys.2011.11.046.

  • 19.

    He X, Zhu Y, Yang L, Wang Z, Wang Z, Feng J, et al. MgFe-LDH Nanoparticles: A Promising Leukemia Inhibitory Factor Replacement for Self-Renewal and Pluripotency Maintenance in Cultured Mouse Embryonic Stem Cells. Adv Sci (Weinh). 2021;8(9):2003535. [PubMed ID: 33977050]. [PubMed Central ID: PMC8097378]. https://doi.org/10.1002/advs.202003535.

  • 20.

    Kumar M, Bishnoi RS, Shukla AK, Jain CP. Techniques for Formulation of Nanoemulsion Drug Delivery System: A Review. Prev Nutr Food Sci. 2019;24(3):225-34. [PubMed ID: 31608247]. [PubMed Central ID: PMC6779084]. https://doi.org/10.3746/pnf.2019.24.3.225.

  • 21.

    Kiani M, Bagherzadeh M, Ghadiri AM, Makvandi P, Rabiee N. Multifunctional green synthesized Cu-Al layered double hydroxide (LDH) nanoparticles: anti-cancer and antibacterial activities. Sci Rep. 2022;12(1):9461. [PubMed ID: 35676410]. [PubMed Central ID: PMC9177833]. https://doi.org/10.1038/s41598-022-13431-7.

  • 22.

    Dasgupta S. Controlled release of ibuprofen using Mg Al LDH nano carrier (IOP Conference Series). Materials Sci and Engineering. 2017;225. https://doi.org/10.1088/1757-899x/225/1/012005.

  • 23.

    Abdel-Hady EE, Mohamed HFM, Hafez SHM, Fahmy AMM, Magdy A, Mohamed AS, et al. Textural properties and adsorption behavior of Zn-Mg-Al layered double hydroxide upon crystal violet dye removal as a low cost, effective, and recyclable adsorbent. Sci Rep. 2023;13(1):6435. [PubMed ID: 37081088]. [PubMed Central ID: PMC10119303]. https://doi.org/10.1038/s41598-023-33142-x.

  • 24.

    Mondal S, Dasgupta S, Maji K. MgAl- Layered Double Hydroxide Nanoparticles for controlled release of Salicylate. Mater Sci Eng C Mater Biol Appl. 2016;68:557-64. [PubMed ID: 27524054]. https://doi.org/10.1016/j.msec.2016.06.029.

  • 25.

    Shi S, Fliss BC, Gu Z, Zhu Y, Hong H, Valdovinos HF, et al. Chelator-Free Labeling of Layered Double Hydroxide Nanoparticles for in Vivo PET Imaging. Sci Rep. 2015;5:16930. [PubMed ID: 26585551]. [PubMed Central ID: PMC4653656]. https://doi.org/10.1038/srep16930.

  • 26.

    Gilanizadeh M, Zeynizadeh B. Synthesis of Acridinediones and Biscoumarins Using Fe3O4@SiO2@Ni–Zn–Fe LDH as an Efficient Magnetically Recoverable Mesoporous Catalyst. Polycyclic Aromatic Compounds. 2019;41(1):15-32. https://doi.org/10.1080/10406638.2019.1567560.

  • 27.

    Mandegary A, Sharififar F, Sheibani V, Nasehi N, Asadi A, Mirtadzadini M, et al. Ameliorating Effect of Standardized Extract From Textured Soy Protein (Glycine max L.) on Memory Deficit and Learning Insufficiency in Scopolamine-induced Amnesia. Basic Clin Neurosci. 2022;13(4):501-10. [PubMed ID: 36561237]. [PubMed Central ID: PMC9759781]. https://doi.org/10.32598/bcn.2021.2446.1.

  • 28.

    Mehrabani M, Jafarinejad-Farsangi S, Raeiszadeh M, Tarzi ME, Sheikholeslami M, Nematollahi MH, et al. Effects of the Ethanol and Ethyl Acetate Extracts of Terminalia chebula Retz. on Proliferation, Migration, and HIF-1alpha and CXCR-4 Expression in MCF-7 Cells: an In Vitro Study. Appl Biochem Biotechnol. 2023;195(5):3327-44. [PubMed ID: 36585552]. https://doi.org/10.1007/s12010-022-04301-z.

  • 29.

    Afsharipour S, Estabragh MAR, Namaki A, Ohadi M, Moshafi MH, Banat IM, et al. Preparation and Physicochemical Properties of a Thermosensitive Hydrogel-based Lipopeptide Biosurfactant. Letters in Drug Design & Discovery. 2024;21. https://doi.org/10.2174/0115701808296878240419065845.

  • 30.

    Fezraoui A, Cornu D, Hébrant M. Fast and efficient chromium(VI) extraction by colloidal Mg/Al layered double hydroxide nanoparticles. Appl Clay Sci. 2024;260. https://doi.org/10.1016/j.clay.2024.107536.

  • 31.

    Kim H, Kim SH, Kim H, Kim YS, Oh J. Surface roughness effect on the cellular uptake of layered double hydroxide nanoparticles. Appl Clay Sci. 2021;202. https://doi.org/10.1016/j.clay.2021.105992.

  • 32.

    Awassa J, Soule S, Cornu D, Ruby C, El-Kirat-Chatel S. Understanding the role of surface interactions in the antibacterial activity of layered double hydroxide nanoparticles by atomic force microscopy. Nanoscale. 2022;14(29):10335-48. [PubMed ID: 35833371]. https://doi.org/10.1039/d2nr02395d.

  • 33.

    Taher T, Putra R, Rahayu Palapa N, Lesbani A. Preparation of magnetite-nanoparticle-decorated NiFe layered double hydroxide and its adsorption performance for congo red dye removal. Chem Physics Letters. 2021;777. https://doi.org/10.1016/j.cplett.2021.138712.

  • 34.

    Januario EFD, Vidovix TB, Beluci NCL, Paixao RM, Silva L, Homem NC, et al. Advanced graphene oxide-based membranes as a potential alternative for dyes removal: A review. Sci Total Environ. 2021;789:147957. [PubMed ID: 34052486]. https://doi.org/10.1016/j.scitotenv.2021.147957.

  • 35.

    Murath S, Szerlauth A, Sebok D, Szilagyi I. Layered Double Hydroxide Nanoparticles to Overcome the Hydrophobicity of Ellagic Acid: An Antioxidant Hybrid Material. Antioxidants (Basel). 2020;9(2). [PubMed ID: 32069950]. [PubMed Central ID: PMC7070634]. https://doi.org/10.3390/antiox9020153.

  • 36.

    Murillo Vázquez RN, Pacheco Moisés FP, Nardello-Rataj V, Arratia-Quijada J, Carbajal Arízaga GG. Composite with natural ingredients and layered double hydroxide nanoparticles as antioxidant and sunscreen powder material. Materials Sci Engineering. 2023;297. https://doi.org/10.1016/j.mseb.2023.116810.

  • 37.

    Bagheri AM, Ranjbar M, Karami-Mohajeri S, Moshafi MH, Dehghan Noudeh Y, Ohadi M, et al. Curcumin Nanoemulgel: Characterization, Optimization, and Evaluation of Photoprotective Efficacy, Anti-Inflammatory Properties, and Antibacterial Activity. J Cluster Sci. 2024;35(7):2253-72. https://doi.org/10.1007/s10876-024-02651-8.

  • 38.

    Malekjani N, Jafari SM. Modeling the release of food bioactive ingredients from carriers/nanocarriers by the empirical, semiempirical, and mechanistic models. Compr Rev Food Sci Food Saf. 2021;20(1):3-47. [PubMed ID: 33443795]. https://doi.org/10.1111/1541-4337.12660.

  • 39.

    Aurelio-Soria D, Canales XH, Vázquez-Garrido I, Islas G, Álvarez-Romero GA, Ibarra IS. Design of Selective Nanoparticles of Layered Double Hydroxide (Mg/Al-LDH) for the Analysis of Anti-Inflammatory Non-Steroidal Agents in Environmental Samples, Coupled with Solid-Phase Extraction and Capillary Electrophoresis. Separations. 2024;11(9). https://doi.org/10.3390/separations11090259.

  • 40.

    Ganjoo R, Soni S, Ram V, Verma A. Medium Molecular Weight Chitosan as a Carrier for Delivery of Lincomycin Hydrochloride from Intra-pocket Dental Film: Design, Development, in vitro and ex vivo Characterization. J Appl Pharmaceutical Sci. 2016:8-19. https://doi.org/10.7324/japs.2016.601002.

  • 41.

    Heredia NS, Vizuete K, Flores-Calero M, Pazmino VK, Pilaquinga F, Kumar B, et al. Comparative statistical analysis of the release kinetics models for nanoprecipitated drug delivery systems based on poly(lactic-co-glycolic acid). PLoS One. 2022;17(3). e0264825. [PubMed ID: 35271644]. [PubMed Central ID: PMC8912140]. https://doi.org/10.1371/journal.pone.0264825.

  • 42.

    Megalathan A, Kumarage S, Dilhari A, Weerasekera MM, Samarasinghe S, Kottegoda N. Natural curcuminoids encapsulated in layered double hydroxides: a novel antimicrobial nanohybrid. Chem Cent J. 2016;10:35. [PubMed ID: 27252776]. [PubMed Central ID: PMC4888422]. https://doi.org/10.1186/s13065-016-0179-7.

  • 43.

    Khashaba PY, Rageh AH, Atia NN, El Zohny SA. Vortex-assisted dispersive solid phase microextraction using Fe(3)O(4)/FeOOH magnetic nanocomposites for high-performance thin-layer chromatographic determination of zolmitriptan in rabbit plasma samples. J Chromatogr A. 2021;1651:462276. [PubMed ID: 34107401]. https://doi.org/10.1016/j.chroma.2021.462276.

  • 44.

    Meili L, Lins PV, Zanta CLPS, Soletti JI, Ribeiro LMO, Dornelas CB, et al. MgAl-LDH/Biochar composites for methylene blue removal by adsorption. Appl Clay Sci. 2019;168:11-20. https://doi.org/10.1016/j.clay.2018.10.012.

  • 45.

    Ahmed IM, Gasser MS. Adsorption study of anionic reactive dye from aqueous solution to Mg–Fe–CO3 layered double hydroxide (LDH). Appl Surface Sci. 2012;259:650-6. https://doi.org/10.1016/j.apsusc.2012.07.092.

  • 46.

    Pandey S, Ramontja J. Recent Modifications of bentonite Clay for Adsorption Applications. Focus on Sci. 2016;2(4):1-10. https://doi.org/10.21859/focsci-020455.

  • 47.

    Daud M, Hai A, Banat F, Wazir MB, Habib M, Bharath G, et al. A review on the recent advances, challenges and future aspect of layered double hydroxides (LDH) – Containing hybrids as promising adsorbents for dyes removal. J Molecular Liquids. 2019;288. https://doi.org/10.1016/j.molliq.2019.110989.

  • 48.

    Yadav BS, Dasgupta S. Effect of time, pH, and temperature on kinetics for adsorption of methyl orange dye into the modified nitrate intercalated MgAl LDH adsorbent. Inorganic Chem Communications. 2022;137. https://doi.org/10.1016/j.inoche.2022.109203.

  • 49.

    de Sá FP, Cunha BN, Nunes LM. Effect of pH on the adsorption of Sunset Yellow FCF food dye into a layered double hydroxide (CaAl-LDH-NO3). Chem Engineering J. 2013;215-216:122-7. https://doi.org/10.1016/j.cej.2012.11.024.

  • 50.

    Shah P, Modi HA. Comparative study of DPPH, ABTS and FRAP assays for determination of antioxidant activity. Int J Res Appl Sci Eng Technol. 2015;3(6):636-41.

  • 51.

    Singh S, Bansal A, Singh V, Chopra T, Poddar J. Flavonoids, alkaloids and terpenoids: a new hope for the treatment of diabetes mellitus. J Diabetes Metab Disord. 2022;21(1):941-50. [PubMed ID: 35673446]. [PubMed Central ID: PMC9167359]. https://doi.org/10.1007/s40200-021-00943-8.

  • 52.

    Moniruzzaman M, Khalil MI, Sulaiman SA, Gan SH. Advances in the analytical methods for determining the antioxidant properties of honey: a review. Afr J Tradit Complement Altern Med. 2012;9(1):36-42. [PubMed ID: 23983317]. [PubMed Central ID: PMC3746522]. https://doi.org/10.4314/ajtcam.v9i1.5.

  • 53.

    Musa Özcan M, Al Juhaimi F. Honey as source of natural antioxidants. J Apicultural Res. 2016;54(3):145-54. https://doi.org/10.1080/00218839.2016.1144976.

  • 54.

    Neupane BP, Chaudhary D, Paudel S, Timsina S, Chapagain B, Jamarkattel N, et al. Himalayan honey loaded iron oxide nanoparticles: synthesis, characterization and study of antioxidant and antimicrobial activities. Int J Nanomedicine. 2019;14:3533-41. [PubMed ID: 31190810]. [PubMed Central ID: PMC6529734]. https://doi.org/10.2147/IJN.S196671.

  • 55.

    Keskin M, Kaya G, Bayram S, Kurek-Gorecka A, Olczyk P. Green Synthesis, Characterization, Antioxidant, Antibacterial and Enzyme Inhibition Effects of Chestnut (Castanea sativa) Honey-Mediated Silver Nanoparticles. Molecules. 2023;28(6). [PubMed ID: 36985734]. [PubMed Central ID: PMC10055715]. https://doi.org/10.3390/molecules28062762.

  • 56.

    Jain KK. An Overview of Drug Delivery Systems. Methods Mol Biol. 2020;2059:1-54. [PubMed ID: 31435914]. https://doi.org/10.1007/978-1-4939-9798-5_1.

  • 57.

    Moyo L, Nhlapo N, Focke WW. A critical assessment of the methods for intercalating anionic surfactants in layered double hydroxides. J Materials Sci. 2008;43(18):6144-58. https://doi.org/10.1007/s10853-008-2935-0.

  • 58.

    Manchun S, Dass CR, Sriamornsak P. Targeted therapy for cancer using pH-responsive nanocarrier systems. Life Sci. 2012;90(11-12):381-7. [PubMed ID: 22326503]. https://doi.org/10.1016/j.lfs.2012.01.008.

  • 59.

    Varrassi G, Pergolizzi JV, Dowling P, Paladini A. Ibuprofen Safety at the Golden Anniversary: Are all NSAIDs the Same? A Narrative Review. Adv Ther. 2020;37(1):61-82. [PubMed ID: 31705437]. https://doi.org/10.1007/s12325-019-01144-9.

  • 60.

    Daher Pereira E, Thomas S, Gomes de Souza Junior F, da Silva Cardoso J, Thode Filho S, Corrêa da Costa V, et al. Study of controlled release of ibuprofen magnetic nanocomposites. J Molecular Structure. 2021;1232. https://doi.org/10.1016/j.molstruc.2021.130067.

  • 61.

    Wang Y, Zhang D, Bao Q, Wu J, Wan Y. Controlled drug release characteristics and enhanced antibacterial effect of graphene oxide–drug intercalated layered double hydroxide hybrid films. J Materials Chem. 2012;22(43). https://doi.org/10.1039/c2jm35144g.

  • 62.

    Fosca M, Rau JV, Uskokovic V. Factors influencing the drug release from calcium phosphate cements. Bioact Mater. 2022;7:341-63. [PubMed ID: 34466737]. [PubMed Central ID: PMC8379446]. https://doi.org/10.1016/j.bioactmat.2021.05.032.

  • 63.

    Salguero Y, Valenti L, Rojas R, Garcia MC. Ciprofloxacin-intercalated layered double hydroxide-in-hybrid films as composite dressings for controlled antimicrobial topical delivery. Mater Sci Eng C Mater Biol Appl. 2020;111:110859. [PubMed ID: 32279819]. https://doi.org/10.1016/j.msec.2020.110859.

  • 64.

    Ranjbar E, Namazi H. Ultrasound-assisted synthesis layered double hydroxide@hydroxyapatite-doxorubicin coated magnetic PEG nanocomposite: A biocompatible pH-sensitive nanocarrier for anticancer drug delivery. FlatChem. 2023;42. https://doi.org/10.1016/j.flatc.2023.100571.